HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GERD surgery vs PPIs

This article was originally published in The Tan Sheet

Executive Summary

Patients with gastroesophageal reflux disease (GERD) who opt for the surgical procedure laparoscopic Nissen fundoplication (LNF) have fewer symptoms long-term than those who manage their condition with proton-pump inhibitors like Prilosec OTC, according to research presented during Digestive Disease Week in Los Angeles, Calif. The study randomly divided 98 chronic GERD patients requiring long-term therapy. One group was treated with PPI, and the other underwent LNF. The researchers checked symptoms every three months and conducted a 24-hour pH test after one year. While symptoms and pH levels improved in both the PPI and surgery groups, the one-year follow up showed surgical patients experienced a significant improvement in symptoms, climbing from 73.3 to 90.2 on a 100-point global rating scale that measured patient satisfaction with symptom control, Mehran Anvari, McMaster University in Ontario, et al., conclude. Meanwhile, the PPI patients' symptoms remained stable. "This minimally invasive surgical procedure may allow some patients to manage GERD symptoms and forego a long-term drug regimen." The study runs counter to a report from Tufts-New England Medical Center Evidence-based Practice Center that concluded that PPIs and surgery are similar in relieving symptoms and decreasing esophageal acid exposure 1("The Tan Sheet" Dec. 19, 2005, p. 5)...

You may also be interested in...



Proton Pump Inhibitors Match Gastro Surgery For GERD Treatment – AHRQ

Prilosec OTC and other PPIs are as effective as surgery for the treatment of gastroesophageal reflux disease (GERD), according to a report released Dec. 14 by the Agency for Healthcare Research & Quality

Probiotics And Cold Remedies Boost Recordati In 2023

Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.

Falling Sales Force New Priorities At Roche

The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel